Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D22.111Melanocytic nevi of right upper eyelid, including canthus

✓ Billable / specific

D22.111 is a valid, billable ICD-10-CM code for melanocytic nevi of right upper eyelid, including canthus. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code last changed in FY2019 (effective October 1, 2018). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D22.111

D22.111 is the ICD-10-CM diagnosis code for Melanocytic nevi of right upper eyelid, including canthus. It belongs to category D22 (Melanocytic nevi), block D10-D36 (benign neoplasms, except benign neuroendocrine tumors) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D22.11 (Melanocytic nevi of right eyelid, including canthus), D22.111 is specifically for Melanocytic nevi of right upper eyelid, including canthus. Related codes cover lower eyelid, including canthus (D22.112).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It was added in FY2019, effective October 1, 2018.

Notes that apply from higher levels

Instructions written at a parent level also apply to D22.111.

› From D22 Melanocytic nevi
Includes
  • atypical nevus
  • blue hairy pigmented nevus
  • nevus NOS

Broader instructions also apply from Chapter 2: Neoplasms.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2019 (effective 10/1/2018): Added
  • No changes since FY2019.

Common questions about D22.111

Is D22.111 billable?

Yes. D22.111 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D22.111 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D22.111 as a principal diagnosis.

Is D22.111 a CC or MCC?

No. D22.111 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D22.111 group to?

D22.111 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.